ClC(OC(C)C)=O.FC(F)(F)C(O)=O.N1CCC(N2C3=NC=NC(OC4C=CC=CC=4C#N)=C3C=N2)CC1.[C:39]([O:43][C:44]([N:46]1[CH2:51][CH2:50][CH:49]([N:52]2[C:56]3=[N:57][CH:58]=[N:59][C:60]([O:61][C:62]4[CH:67]=[CH:66][CH:65]=[CH:64][C:63]=4[C:68]#[N:69])=[C:55]3[CH:54]=[N:53]2)[CH2:48][CH2:47]1)=[O:45])(C)([CH3:41])[CH3:40].FC(F)(F)C(O)=O.C(OC1C=CC(OC2N=CN=C3N(C4CCNCC4)N=CC=23)=C(F)C=1)C.C(N(C(C)C)CC)(C)C>ClCCl.O>[CH:39]([O:43][C:44]([N:46]1[CH2:47][CH2:48][CH:49]([N:52]2[C:56]3=[N:57][CH:58]=[N:59][C:60]([O:61][C:62]4[CH:67]=[CH:66][CH:65]=[CH:64][C:63]=4[C:68]#[N:69])=[C:55]3[CH:54]=[N:53]2)[CH2:50][CH2:51]1)=[O:45])([CH3:41])[CH3:40]Isopropyl chloroformate (Aldrich Chemical Company, Inc., Milwaukee, Wis., USA 1M in toluene; 0.34 mL, 0.34 mmol) was added to a mixture of 2-(1-piperidin-4-yl-1H-pyrazolo[3,4-d]pyrimidine-4-yloxy)-benzonitrile trifluoroacetate salt (which was prepared from 4-[4-(2-cyano-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester [Example 45] following the procedure described for the preparation of Intermediate 29; 150 mg, 0.344 mmol), diisopropylethylamine (133 mg, 1.03 mmol) in dichloromethane (6 mL). The reaction was stirred at room temperature overnight. Water was added to quench the reaction and the aqueous layer was extracted three times with dichloromethane. The combined organic layers were dried (sodium sulfate), filtered, evaporated and purified by flash chromatography on silica gel, eluting with 4% methanol/dichloromethane to give 4-[4-(2-cyano-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid isopropyl ester (98 mg, 70%) as a white solid. Mass spectrum MH+=407.
Loading…